Rather than reflecting a simple imbalance between energy intake and expenditure, obesity represents an actively defended physiological state in which compensatory mechanisms promote weight regain following weight loss attempts ( Among these strategies, glucagon-like peptide-1 receptor agonists (GLP-1RAs) have emerged as the most effective anti-obesity pharmacotherapies to date
Its not a GLP-1 like Ozempic or Wegovy, but its also not a traditional appetite suppressant pill nor does it just completely halt your metabolism in its tracks
CHALLENGES AND ADHERENCE Despite its efficacy, CPAP adherence remains a challenge, with studies reporting 30-50% non-adherence rates
Start with a short assessment to see if this approach aligns with your goals
While the studies above were observational, Dr Allison Ross Eckard from the Medical University of South Carolina and colleagues reported new findings from a randomised controlled trial of semaglutide versus a placebo in people with HIV, focusing on subclinical cardiovascular health